General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0GSDAM
ADC Name
WO2022228495A1 ADC-78
Synonyms
WO2022228495A1-ADC-78
   Click to Show/Hide
Organization
Shanghai Huilun Pharmaceutical Co., Ltd.
Drug Status
Investigative
Indication
In total 2 Indication(s)
Breast cancer
Investigative
.
Lung squamous cell carcinoma
Investigative
.
Drug-to-Antibody Ratio
4
Antibody Name
Sacituzumab
 Antibody Info 
Antigen Name
Tumor-associated calcium signal transducer 2 (TROP2)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
WO2022228495A1 ADC-78 linker